ProscsVax vaccine looks promising

They are starting phase 2 trials. Anyone know if enrollment is still open?
https://prostatecancernewstoday.com/2017/11/14/trial-shows-proscavax-prostate-cancer-vaccine-halted-progression-in-80-percent-of-patients/

This study is closed now. But they will have to do more studies to get FDA approval for it.

George

The Sotio company has already closed their Phase III trial. Lets hope they can show a benefit and there will be an alternative for Provenge.

Post Edited (George_) : 1/26/2018 6:11:10 AM (GMT-7)

That's interesting that they are using interleukin-2...high dose IL2 though a much different treatment is the only treatment to date that has put a small subset of kidney cancer patients into a no evidence of disease state for many years.

I can't tell if the trial has actually started accruing though. Their press releases are a bit vague only saying that it's at "a major Northeast U.S. university cancer research hospital evaluating ProscaVax as a front-line therapy in prostate cancer patients in the “active surveillance” category"...

http://oncbiomune.com/2018/01/10/70-of-advanced-prostate-cancer-patients-treated-with-proscavax-demonstrate-improvement-in-psa-doubling-time/


Nonetheless I look forward to seeing more about treatment.